Guizhou Bailing Group Pharmaceutical Co., Ltd. Share Price
Stocks
002424
CNE100000PY3
Pharmaceuticals
|
End-of-day quote
Shenzhen S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 4.690 CNY | +1.30% |
|
+1.30% | +7.82% |
| 09-17 | Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream | MT |
| 09-01 | Guizhou Bailing Group Pharmaceutical Gets China Clinical Trial Approval for COPD Drug | MT |
| Market Cap | 6.4B 955M 853M 796M 723M 1.36B 92.36B 1.37B 9.56B 3.74B 46.97B 3.58B 3.51B 151B | P/E 2024 |
193x | P/E 2025 | -54.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.28B 1.09B 970M 905M 822M 1.55B 105B 1.56B 10.87B 4.25B 53.39B 4.07B 3.99B 172B | EV / Sales 2024 |
1.74x | EV / Sales 2025 | 2.23x |
| Free-Float |
66.81% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.30% | ||
| 1 week | +1.30% | ||
| 1 month | +2.18% | ||
| 3 months | +2.63% | ||
| 6 months | -5.63% | ||
| Current year | +7.82% |
| 1 month | 4.4 |  | 4.88 |
| Current year | 4.08 | | 5.47 |
| 1 year | 4.08 | | 6.43 |
| 3 years | 2.98 | | 8.8 |
| 5 years | 2.98 | | 11.97 |
| 10 years | 2.98 | | 23.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Niu
CEO | Chief Executive Officer | 56 | 01/04/2015 |
Hong Xing Li
DFI | Director of Finance/CFO | 41 | 28/12/2020 |
Pei Chen
PRN | Corporate Officer/Principal | 42 | 26/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Min Niu
CHM | Chairman | 56 | 26/03/2026 |
Yong Jiang
BRD | Director/Board Member | 58 | 24/12/2007 |
Pei Chen
BRD | Director/Board Member | 42 | 26/01/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/20 | Sell | Chairman | 1,940,600 | 0.2495% | ||
| 18/09/20 | Sell | Director | 3,670,000 | 0.4719% | ||
| 18/09/20 | Sell | Chairman | 296,500 | 0.0381% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | +1.30% | -10.67% | -41.81% | 955M | |
| +2.83% | +2.67% | +40.82% | +107.77% | 1,032B | |
| +1.49% | -2.30% | +36.93% | +63.14% | 614B | |
| +1.82% | +3.77% | +16.59% | +82.05% | 471B | |
| +0.61% | -1.78% | +62.92% | +36.58% | 350B | |
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | |
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.40% | -1.91% | +39.90% | +52.26% | 218B | |
| +1.79% | -1.46% | +25.77% | +95.68% | 179B | |
| Average | +1.67% | -2.49% | +24.58% | +48.88% | 371.58B | |
| Weighted average by Cap. | +1.88% | -3.18% | +31.95% | +69.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.83B 571M 510M 476M 432M 814M 55.19B 820M 5.72B 2.23B 28.07B 2.14B 2.1B 90.23B | 3.05B 455M 406M 379M 344M 648M 43.98B 653M 4.55B 1.78B 22.37B 1.71B 1.67B 71.91B |
| Net income | 33.62M 5.01M 4.48M 4.18M 3.8M 7.15M 485M 7.2M 50.23M 19.63M 247M 18.83M 18.42M 793M | -104M -15.57M -13.91M -12.98M -11.79M -22.2M -1.51B -22.36M -156M -60.92M -766M -58.44M -57.17M -2.46B |
| Net Debt | 1.4B 209M 187M 174M 158M 298M 20.2B 300M 2.09B 817M 10.27B 784M 767M 33.03B | 875M 130M 117M 109M 98.78M 186M 12.62B 187M 1.31B 511M 6.42B 490M 479M 20.63B |
Employees
5,715
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥4.690 | +1.30% | 7,182,100 |
| 29/09/26 | CN¥4.630 | -1.70% | 9,866,900 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002424 Stock
Select your edition
All financial news and data tailored to specific country editions
